Shandong Polymer Biochemicals Co., Ltd.

SZSE:002476.SZ

4.64 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202420232022202120202019201820172016201520142013201220112010200920082007
Revenue 538.663387.338592.285657.16447.315416.892449.891409.828898.01741.647667.607684.983581.184542.852515.41419.457542.754447.387
Cost of Revenue 439.682322.268462.682557.067363.638365.11398.931353.686725.122611.678539.338568.921493.462436.02410.239327.311457.26382.736
Gross Profit 98.9865.07129.603100.09383.67651.78250.9656.142172.888129.969128.269116.06287.722106.832105.17192.14585.49464.651
Gross Profit Ratio 0.1840.1680.2190.1520.1870.1240.1130.1370.1930.1750.1920.1690.1510.1970.2040.220.1580.145
Reseach & Development Expenses 20.39117.98425.48622.39817.91819.64618.55715.69226.21421.93620.9522.1683.6572.3622.063000
General & Administrative Expenses 40.96846.1947.42338.4224.59334.35835.39771.70673.84162.64850.25338.35320.858.4946.15513.82114.4115.466
Selling & Marketing Expenses 8.02812.31724.35913.3658.01411.63115.48814.4862.28326.00511.9339.5268.2936.7887.2537.2967.6366.681
SG&A 16.23426.30773.74150.78537.45146.48228.61141.181121.31144.78723.38419.42616.93215.28220.40722.32324.2413.421
Other Expenses -38.9339.99341.24828.87819.65227.226109.278-15.08029.466000017.19513.55110.8748.168
Operating Expenses 41.31954.28498.87381.91666.38476.206203.00856.494174.013150.26169.08660.9133.82530.80426.46222.34924.81213.455
Operating Income 55.89110.78630.7318.17726.823-24.424-152.048-1.343-1.132-20.29359.18355.15158.65379.2472.50457.47846.74541.168
Operating Income Ratio 0.1040.0280.0520.0280.06-0.059-0.338-0.003-0.001-0.0270.0890.0810.1010.1460.1410.1370.0860.092
Total Other Income Expenses Net 5.884-0.1490.345-0.477-9.773116.813-121.3593.467.15623.6650.7111.182.1040.8213.341-0.024-0.254-1.87
Income Before Tax 61.77610.63731.07517.70117.0592.389-273.4072.1176.0323.37259.89456.33260.75780.06175.84457.45346.49139.298
Income Before Tax Ratio 0.1150.0270.0520.0270.0380.222-0.6080.0050.0070.0050.090.0820.1050.1470.1470.1370.0860.088
Income Tax Expense 5.3825.4031.372-0.2473.8681.143-9.3211.72811.43813.25111.5629.3539.58912.25819.03114.63811.80913.511
Net Income 56.3945.23329.70317.94813.18391.246-264.0868.2714.8324.13847.9146.93251.24967.80356.81342.81534.68225.788
Net Income Ratio 0.1050.0140.050.0270.0290.219-0.5870.020.0170.0330.0720.0690.0880.1250.110.1020.0640.058
EPS 0.0920.0090.0480.0290.0220.15-0.430.0140.0240.0390.0780.0770.0840.130.150.110.0870.073
EPS Diluted 0.0920.0090.0480.0290.0220.15-0.430.0140.0240.0390.0780.0770.0840.130.150.110.0870.073
EBITDA 84.48335.92666.44361.28967.394144.482-208.49444.48775.42581.032103.3593.37693.628103.71107.04494.43883.75572.607
EBITDA Ratio 0.1570.0930.1120.0930.1510.347-0.4630.1090.0840.1090.1550.1360.1610.1910.2080.2250.1540.162